Targeting Cell Metabolism in Cancer Patients | Science Translational Medicine

Skip to main content

ScienceMag.org

Article Information

vol. 2 no. 31 31ed1

DOI:

https://doi.org/10.1126/scitranslmed.3001210

PubMed:

Published By:

American Association for the Advancement of Science

Print ISSN:

Online ISSN:

History:

.

Copyright & Usage:

Copyright © 2010, American Association for the Advancement of Science

Author Information

Matthew G. Vander Heiden

David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology,
Cambridge, MA 02139, USA. E-mail: mvh{at}mit.edu

Altmetric

Article usage

Article usage: May 2010 to December 2019

	Abstract	Full	Pdf
May 2010	0	377	415
Jun 2010	0	59	87
Jul 2010	0	29	37
Aug 2010	0	35	29
Sep 2010	0	49	50
Oct 2010	0	39	31
Nov 2010	0	42	38
Dec 2010	0	75	40
Jan 2011	0	38	34
Feb 2011	0	25	18
Mar 2011	0	27	25
Apr 2011	0	35	27
May 2011	0	72	76
Jun 2011	0	57	23
Jul 2011	0	42	15
Aug 2011	0	67	27
Sep 2011	0	51	21
Oct 2011	0	56	16
Nov 2011	0	66	11
Dec 2011	0	57	15
Jan 2012	0	84	19
Feb 2012	0	45	15
Mar 2012	0	161	20
Apr 2012	0	53	17
May 2012	0	50	12
Jun 2012	0	29	10
Jul 2012	0	29	17
Aug 2012	0	38	10
Sep 2012	0	46	17
Oct 2012	0	28	12
Nov 2012	0	49	15
Dec 2012	0	36	8
Jan 2013	0	48	8
Feb 2013	0	41	6
Mar 2013	0	37	3
Apr 2013	0	49	8
May 2013	0	68	16
Jun 2013	0	36	5
Jul 2013	0	64	8
Aug 2013	0	23	1
Sep 2013	3	40	3
Oct 2013	17	30	15
Nov 2013	5	38	6
Dec 2013	1	39	2
Jan 2014	0	39	5
Feb 2014	1	33	7
Mar 2014	1	29	9
Apr 2014	3	36	5
May 2014	0	29	6
Jun 2014	1	27	6
Jul 2014	2	21	9
Aug 2014	0	22	2
Sep 2014	0	21	9
Oct 2014	6	30	13
Nov 2014	1	20	5
Dec 2014	6	20	4
Jan 2015	0	29	13
Feb 2015	1	22	4
Mar 2015	0	20	6
Apr 2015	9	13	2
May 2015	0	12	6
Jun 2015	0	7	2
Jul 2015	0	3	1
Aug 2015	0	3	3
Sep 2015	0	13	6
Oct 2015	0	4	0
Nov 2015	0	4	2
Dec 2015	0	1	1
Jan 2016	0	7	1
Feb 2016	0	3	0
Mar 2016	0	6	4
Apr 2016	0	4	6
May 2016	0	9	7
Jun 2016	0	10	2
Jul 2016	0	11	5
Aug 2016	0	5	5
Sep 2016	0	7	4
Oct 2016	0	3	3
Nov 2016	0	3	2
Dec 2016	0	1	0
Jan 2017	0	9	4
Feb 2017	0	10	2
Mar 2017	0	7	1
Apr 2017	0	5	2
May 2017	0	4	1
Jun 2017	0	4	3
Jul 2017	0	9	1
Aug 2017	0	6	1
Sep 2017	0	6	3
Oct 2017	0	6	4
Nov 2017	0	9	2
Dec 2017	0	9	4
Jan 2018	0	3	1
Feb 2018	0	7	1
Mar 2018	0	13	5
Apr 2018	0	11	3
May 2018	0	18	7
Jun 2018	0	8	2
Jul 2018	0	7	0
Aug 2018	0	6	6
Sep 2018	0	13	12
Oct 2018	0	11	4
Nov 2018	0	10	4
Dec 2018	0	8	4
Jan 2019	0	9	3
Feb 2019	0	5	5
Mar 2019	0	6	3
Apr 2019	0	5	2
May 2019	0	8	2
Jun 2019	0	6	4
Aug 2019	0	5	2
Sep 2019	0	10	1
Oct 2019	0	8	2
Nov 2019	0	4	3
Dec 2019	0	2	2

Science Translational Medicine: 2 (31)

Science Translational Medicine

Vol 2, Issue 31
12 May 2010

Table of Contents

Article Tools

Email

Thank you for your interest in spreading the word about Science Translational Medicine.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email

Your Name

Send To
Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Targeting Cell Metabolism in Cancer Patients

Message Subject (Your Name) has forwarded a page to you from Science Translational Medicine

Message Body (Your Name) thought you would like to see this page from the Science Translational Medicine web site.

Your Personal Message
Download Powerpoint
Print
Save to my folders

Log In with your AAAS Login
Alerts

Please log in to add an alert for this article.

Log In with your AAAS Login

Sign In to Email Alerts with your Email Address
Email
Citation tools
Targeting Cell Metabolism in Cancer Patients

By Matthew G. Vander Heiden

Science Translational Medicine12 May 2010 : 31ed1

Dichloroacetate can safely modify glucose metabolism in aggressive brain tumors when administered to patients.

Citation Manager Formats

BibTeX

Bookends

EasyBib

EndNote (tagged)

EndNote 8 (xml)

Medlars

Mendeley

Papers

RefWorks Tagged

Ref Manager

RIS

Zotero
Share

Targeting Cell Metabolism in Cancer Patients

By Matthew G. Vander Heiden

Science Translational Medicine12 May 2010 : 31ed1

Dichloroacetate can safely modify glucose metabolism in aggressive brain tumors when administered to patients.

Share This Article:

Citing Articles in: